Minerva Neurosciences, Inc.
NERVNasdaqCIK 1598646HealthcareFiscal year ends Dec 31
Reports and events: 216 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-346817 |
| 2026-08-0707:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-339171 |
| 2026-08-0707:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-339147 |
| 2026-06-0416:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-257379 |
| 2026-05-2716:18 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-241930 |
| 2026-05-0508:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-205182 |
| 2026-05-0508:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-205129 |
| 2026-04-2307:00 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001193125-26-171799 |
| 2026-04-0617:07 ET | 8-K | 8.01 Other events | 0001193125-26-143986 |
| 2026-04-0216:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-140148 |
| 2026-03-1108:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-101117 |
| 2026-03-1107:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-101074 |
| 2026-02-0309:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-26-034538 |
| 2025-12-3016:05 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-337075 |
| 2025-12-2216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-328715 |
| 2025-11-2416:05 ET | DEF 14A | Proxy statementPeriod 2025-12-22 | 0001193125-25-293674 |
| 2025-11-1908:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-287048 |
| 2025-11-0507:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-265685 |
| 2025-10-2220:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-245552 |
| 2025-08-1416:03 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108840 |
| 2025-05-1307:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069780 |
| 2025-04-2918:46 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001193125-25-100977 |
| 2025-04-2116:55 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001193125-25-087311 |
| 2025-03-1916:43 ET | 8-K | 8.01 Other events | 0001193125-25-057901 |
| 2025-02-2506:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-026055 |
| 2025-01-1308:46 ET | 8-K | 8.01 Other events | 0001193125-25-005042 |
| 2024-12-0517:21 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-271652 |
| 2024-11-0507:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-121063 |
| 2024-10-2207:06 ET | DEF 14A | Proxy statementPeriod 2024-12-05 | 0001193125-24-240733 |
| 2024-10-1116:10 ET | 8-K | 3.01 Delisting notice | 0001193125-24-236726 |
| 2024-09-1616:05 ET | 8-K | 8.01 Other events | 0001193125-24-219590 |
| 2024-08-0607:01 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091195 |
| 2024-05-3016:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-150357 |
| 2024-05-0107:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-050883 |
| 2024-04-2217:07 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001193125-24-105033 |
| 2024-04-1216:05 ET | 8-K | 3.01 Delisting notice | 0001193125-24-094620 |
| 2024-02-2708:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-047110 |
| 2024-02-2617:32 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001193125-24-044724 |
| 2024-02-2206:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-018392 |
| 2023-11-0707:00 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-059747 |
| 2023-09-2816:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-245615 |
| 2023-08-1509:25 ET | DEF 14A | Proxy statementPeriod 2023-09-27 | 0001193125-23-213100 |
| 2023-08-0107:01 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-036159 |
| 2023-07-0716:18 ET | SC 13D | Ownership report, active investor | 0001193125-23-183809 |
| 2023-06-2808:37 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-176877 |
| 2023-06-2008:41 ET | 8-K | 8.01 Other events | 0001193125-23-169682 |
| 2023-06-0216:05 ET | 8-K | 3.01 Delisting notice | 0001193125-23-159827 |
| 2023-05-1507:01 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021947 |
| 2023-05-0516:18 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-137134 |
| 2023-05-0107:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-128726 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:30 ET. Listed shows no prices and gives no investment advice.